Kintsugi is on a mission to scale access to mental healthcare for all. We are developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI companies to watch in 2022 and Fierce 15 in 2023, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimately saving time and lives.

At Kintsugi, we believe that mental health is just as important as physical health. We exist to ensure that everyone who needs mental healthcare has access to the right care at the right time.